Schwandt, A., Mekhail, T., Halmos, B., O'Brien, T., Ma, P. C., Fu, P., . . . Dowlati, A. (2012). Brief Report: Phase II Trial of Rebeccamycin Analogue, a Dual Topoisomerase I and II Inhibitor, in Relapsed “Sensitive” Small Cell Lung Cancer.
Chicago Style citaatSchwandt, Anita, Tarek Mekhail, Balazs Halmos, Timothy O'Brien, Patrick C. Ma, Pingfu Fu, Percy Ivy, en Afshin Dowlati. Brief Report: Phase II Trial of Rebeccamycin Analogue, a Dual Topoisomerase I and II Inhibitor, in Relapsed “Sensitive” Small Cell Lung Cancer. 2012.
MLA citatieSchwandt, Anita, et al. Brief Report: Phase II Trial of Rebeccamycin Analogue, a Dual Topoisomerase I and II Inhibitor, in Relapsed “Sensitive” Small Cell Lung Cancer. 2012.
Let op: Deze citaties zijn niet altijd 100% accuraat.